REDEEMABLE CONVERTIBLE PREFERRED STOCK, ESCROWED PROCEEDS, AND STOCKHOLDERS EQUITY (Details Narrative) - USD ($)		1 Months Ended		12 Months Ended
	May 11, 2022	Dec. 16, 2022	Oct. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Net proceeds from issue of stocks				$ 10,143,152	$ 0
Stock based compensation, options				794,735	1,563,686
Unrecognized compensation cost related to unvested options				$ 1,670,986
Weighted average expected recognized period				2 years 7 months 6 days
Number of common stock share				798,182
Fees and expenses				$ 9,109,117
Voting of shares description				The holders of Series C Preferred Stock were entitled to 20,000 votes per share
Exercise price per share			$ 5.83
Exercise price			$ 0.0001
Description of commission				The Company pays Canaccord 3.0% of the gross proceeds as a commission
Unvested performance-based restricted stock				$ 238,838	60,566	$ 95,167	$ 87,303
Unvested performance-based stock options granted to executive officers and other employees				318,813
Unvested performance-based stock options granted				57,999
Stock based compensation, restricted stock units				$ 616,182	941,852
Outstanding vested restricted stock unit				356,003
Description of securities purchase			1,020,000 shares of the Company’s common stock, (ii) prefunded warrants (the “Pre-Funded Warrants”) to purchase up to 798,182 shares of the Company’s common stock, and (iii) common stock warrants (the “Common Warrants”) to purchase up to 1,818,182 shares of the Company’s common stock. Each share of common stock was offered with one accompanying Common Warrant with a combined offering price of $5.50. Each Pre-Funded Warrant was offered with one accompanying Common Warrant with a combined offering price of $5.4999
Total gross proceeds				$ 15,000,000
Selling, general and administrative expenses				$ 15,290,836	$ 16,511,942
2023 Equity Distribution Agreement [Member]
Sale of common stock				504,034
Payment of commission				$ 35,902
Net proceeds from issue of stocks				1,034,035
Other related expenses				$ 126,801
Description of equity distribution agreement				The 2023 Equity Distribution Agreement and related prospectus is limited to sales of up to an aggregate maximum $50.0 million of shares of the Company’s common stock
Vesting of restricted share units				20,468	16,191
Vesting of restricted share units value aggregate				$ 146,062	$ 221,311
Executive Officers
Unvested performance-based restricted stock units granted				152,432	40,707	22,343	52,679
Other Employees
Outstanding restricted stock units					$ 217,833
Unvested performance-based restricted stock units granted					37,116
2011 Stock Incentive Plan [Member]
Incentive for nonqualified stock option grants, restricted stock unit awards and other stock-based awards to employees, non-employee directors and consultants				3,300,000
Shares available for grant				405,145
2011 Stock Incentive Plan [Member] | President and CEO [Member]
Voluntarily contributed stock options number of share		143,360
2011 Stock Incentive Plan [Member] | CFO and COO [Member]
Voluntarily contributed stock options number of share		124,220
Series B Convertible Preferred Stock
Fee					$ 750,000
Selling, general and administrative expenses					150,995
Fair value of the warrants					$ (234,443)
Convertible Series A Preferred Stock
Convertible preferred stock were outstanding				4,030
Aggregate value				$ 403,000
Conversion price				$ 114.77
Convertible shares				$ 0.66
Distributable value of dividend				$ 100
Distributable value of dividend additional				100
Series B Redeemable Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member]
Shares sold	8,100,000
Series C Redeemable Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member]
Shares sold	900,000
Share purchase price	$ 1.67
Series B and C Redeemable Convertible Preferred Stock [Member] | Securities Purchase Agreement Plan [Member]
Exercise price	$ 12.50
Account to release				15,750,000
Fee				750,000
Warrants to purchase up	66,666
Total gross proceeds from the offering				$ 15,000,000
Expiry of share issuance	48 months